128 related articles for article (PubMed ID: 36006493)
1. ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data.
Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
Ann Surg Oncol; 2022 Dec; 29(13):8261-8262. PubMed ID: 36006493
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: The Accurate Prognostic Evaluation and Optimal Treatment Strategy for Ampulla of Vater Carcinoma.
Imamura T; Yamamoto Y; Uesaka K
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):621-622. PubMed ID: 31115854
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: The Prognostic Significance of LODDS in Medullary Thyroid Carcinoma.
Tang J; Jiang S; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4371-4372. PubMed ID: 33521901
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
Sun C; Anraku M; Nakajima J
Ann Surg Oncol; 2022 Mar; 29(3):1825-1826. PubMed ID: 34802103
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Prognostic Significance of Perineural Invasion in Upper Tract Urothelial Carcinoma.
Lin TW; Yeh HC
Ann Surg Oncol; 2022 May; 29(5):3318-3319. PubMed ID: 34978673
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Revisiting the Prognostic Significance of Grade in Papillary Thyroid Carcinoma.
Ho AS; Sacks WL; Zumsteg ZS
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):852-853. PubMed ID: 32864730
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma.
Yoh T; Seo S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):780-781. PubMed ID: 30264250
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Pancreatic Invasion is a Crucial Independent Prognostic Factor in Duodenal Carcinoma.
Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Sasaki K; Uesaka K
Ann Surg Oncol; 2020 Oct; 27(11):4561. PubMed ID: 32462525
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients.
Chattopadhyay A; Wu CH; Tien YW; Lu TP
Ann Surg Oncol; 2022 Mar; 29(3):1616-1617. PubMed ID: 34802101
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Future Perspectives of Novel Prognostic Predictor of Vessels that Encapsulate Tumor Cluster (VETC) for Hepatocellular Carcinoma.
Toshima T; Yoshizumi T; Itoh S; Toshida K; Tomiyama T; Morinaga A; Kosai-Fujimoto Y; Tomino T; Kurihara T; Morita K; Harada N
Ann Surg Oncol; 2021 Dec; 28(13):8196-8197. PubMed ID: 34327602
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
Shinohara S; Kobayashi K; Nakagawa M
Ann Surg Oncol; 2020 Feb; 27(2):490-491. PubMed ID: 31659635
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1558-1559. PubMed ID: 32166592
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Incorporating Lymphovascular Invasion to Improve the Prognostic Reliability of the T-Staging System for Adrenocortical Carcinoma-A Multicenter Study.
Poorman CE; Ethun CG; Maithel SK
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):862-863. PubMed ID: 30298330
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Prognostic Role of Pathologic Complete Response After Neoadjuvant Therapy in Digestive Cancer.
Wan T; Zhou YM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):587. PubMed ID: 31011901
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
Matsubara T; Okamoto T
Ann Surg Oncol; 2021 Jun; 28(6):3055-3056. PubMed ID: 33095364
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
Kitamura Y; Oshikiri T
Ann Surg Oncol; 2021 Aug; 28(8):4529. PubMed ID: 33399999
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: The Naples Prognostic Score Predicts Long-Term Survival in Patients with Resected Pancreatic Cancer.
Nakagawa N; Yamada S; Kodera Y
Ann Surg Oncol; 2020 Mar; 27(3):896-897. PubMed ID: 31848821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
